These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2066457)

  • 1. Clonazepam: sleep laboratory study of efficacy and withdrawal.
    Kales A; Manfredi RL; Vgontzas AN; Baldassano CF; Kostakos K; Kales JD
    J Clin Psychopharmacol; 1991 Jun; 11(3):189-93. PubMed ID: 2066457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diazepam: effects on sleep and withdrawal phenomena.
    Kales A; Soldatos CR; Bixler EO; Kales JD; Vela-Bueno A
    J Clin Psychopharmacol; 1988 Oct; 8(5):340-6. PubMed ID: 3183072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.
    Greenblatt DJ; Harmatz JS; Zinny MA; Shader RI
    N Engl J Med; 1987 Sep; 317(12):722-8. PubMed ID: 3306380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
    Herman JB; Brotman AW; Rosenbaum JF
    J Clin Psychiatry; 1987 Oct; 48 Suppl():22-8. PubMed ID: 2889722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
    J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
    Gann H; Feige B; Cloot O; Van Wasen H; Zinzgraf D; Hohagen F; Riemann D
    Pharmacopsychiatry; 2004 Sep; 37(5):228-35. PubMed ID: 15359376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebound insomnia: duration of use and individual differences.
    Merlotti L; Roehrs T; Zorick F; Roth T
    J Clin Psychopharmacol; 1991 Dec; 11(6):368-73. PubMed ID: 1770156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebound insomnia: a critical review.
    Gillin JC; Spinweber CL; Johnson LC
    J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.
    Saletu B; Kindshofer G; Anderer P; Grünberger J
    Int J Clin Pharmacol Res; 1987; 7(5):407-18. PubMed ID: 2889679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.
    Fleming JA; McClure DJ; Mayes C; Phillips R; Bourgouin J
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():29-37. PubMed ID: 2201728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term efficacy and withdrawal of zopiclone: a sleep laboratory study.
    Pecknold J; Wilson R; le Morvan P
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():57-67. PubMed ID: 2117623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N; Nakajima T; Hayash K; Nose I; Hashizume Y; Ohyama T; Habukawa M; Kotorii N; Kuwahara H; Maeda H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.
    Mouret J; Ruel D; Maillard F; Bianchi M
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():47-55. PubMed ID: 2201730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P; Nir T; Laudon M; Zisapel N
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study.
    Mitler MM; Seidel WF; van den Hoed J; Greenblatt DJ; Dement WC
    J Clin Psychopharmacol; 1984 Feb; 4(1):2-13. PubMed ID: 6141188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygraphical sleep recordings in insomniac patients under zopiclone or nitrazepam.
    Jovanovic UJ; Dreyfus JF
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():136-45. PubMed ID: 7188371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.